Category: News

The prospective dataset will initially be collected from patients participating in clinical trials initiated by us in multiple hospitals. Yamicc has now developed the ‘ReDiReCCT-GB trial’ within Erasmus MC and has recently started. In this clinical study, in principle, every new patient with a glioblastoma will participate and be followed from diagnosis. Each patient’s tumor…

Yamicc is developing a data platform that focuses on easily and securely collecting, processing, and sharing all relevant information. Our data platform, called DataBridge, is designed to make the desired data accessible for the public benefit, including primary care innovation and scientific research. The unlocking, integration, and analysis of data will be made possible from…

Creating sustainable partnerships with hospitals, research institutions, other cancer organizations, and patient advocacy groups is a crucial pillar in our approach. We have started a proactive partner program to connect new organizations and provide current partners with all the necessary support to use our data platform. Our successful experience and knowledge in applying ICT to…